Partnerships, business and growth at CPhI 2018 Madrid

Hosted in the landscape of one of Europe’s burgeoning biotech and pharma hubs, CPhI Worldwide promises to be an unmissable opportunity to discover the latest and most innovative advancements, catch up with old contacts and form vital new partnerships that will push the industry to the next level

picture of

Breaking News

PCI announces new facility dedicated to clinical trial returns

Continued investment at Bridgend site enables capacity expansion for segregated space in support of the return of ...

Chanelle Pharma invests €86m in manufacturing

The generic pharmaceutical manufacturer will put part of the investment towards building a dedicated manufacturing ...

C2 Pharma and Theracule announce strategic partnership

C2 Pharma will manufacture a botanical extract for Theracule, as well as lead the seed funding of the company that ...

Middle East and Africa pharma economy to reach US$38.8 bn by 2021

CPhI Middle East and Africa opens in Abu Dhabi as finished dosage formulations expand quickly, driven by government ...

Catalent invests $7.3 million in Italian facility

The oral and topical softgel technology specialist is aiming to solve complex bioavailability and formulation challenges

Warning to pharma manufacturers in annual CPhI report

Pharmaceutical manufacturers that do not invest in continuous manufacturing will be forced out of market predicts CPhI ...

A new way of buying and selling APIs, additives, vitamins and excipients

Swiss Kemiex and Atradius credit insurance launch unique commodity trading platform for the pharmaceutical and ...

Innovate UK awards Medherant a medicines manufacturing grant

The grant will enable the company to extend its pilot scale manufacture of patches formulated with its unique TEPI ...

Patients could lose out on life-saving treatments

Limited access to novel therapies could hinder effective personalised cancer treatment in the UK, says GlobalData

Open tech standards hold the key to better sponsor-CRO collaboration

Sponsors are under ever-increasing pressure to reduce the cost of drug development while accelerating time-to-market, ...

A look back at 2017 healthcare transactions

Last year, 2017, saw 2011 deals complete, with Q2 showing the strongest performance with 29.4%, followed by Q1 with 27. ...

Global partnership to expand pharma biocatalysis uptake

Codexis, Inc. and Porton Pharma Solutions recently announced a strategic collaboration to deploy Codexis’ world-leading ...

NHS wins case to prescribe cheaper ophthalmology drug

According to GlobalData, NHS' victory in the Bayer and Novartis case could have a significant impact on UK o ...

Lonza offers complete product lifecycle management at one location

The expansion includes drug substance development, and drug substance and drug product manufacturing, which will allow ...